◼ Archived
Business
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment
The FDA's approval of Lantheus' brain-imaging agent for Alzheimer's assessment is making waves in the medical and business communities.
Pet Imaging
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Pet Imaging
This hub groups 2 separate news trends connected to Pet Imaging, spanning July 16, 2026 through August 14, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 12 article observations and 12 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Imaging study reveals widespread brain connection loss in schizophrenia
Recent imaging studies have uncovered significant brain connectivity loss in individuals with schizophrenia.